FDA Approval of Nexviazyme (avalglucosidase alfa) For Treatment of Late-Onset Pompe Disease
Mazen M. Dimachkie, MD, FAAN, FANA, Neuromuscular Division Chief at The University of Kansas Health System, discusses Pompe disease, a progressive muscle disorder that impairs a person’s ability to move and breathe, and what the FDA approval of Nexviazyme ® (avalglucosidase alfa) means to the Pompe community.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Treatment. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Treatment and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Treatment?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Dr. Dimachkie is a Professor of Neurology, Executive Vice Chairman and Vice Chairman for Research Programs and Director of the Neuromuscular Division in the Department of Neurology at the University of Kansas Medical Center. As the director of KU Medical Center for Neuromuscular Research, he manages one of the busiest neuromuscular clinical trials units in North America.
He received his medical degree from the American University of Beirut in Lebanon before completing two years of training in Internal Medicine at Saint Agnes Hospital in Baltimore, Maryland. Dr. Dimachkie then completed a residency in Neurology at UT-Houston and fellowship in electromyography and Neuromuscular Disease, both at the University of Texas Health Science Center at Houston (UT-Houston).
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
